The Gross Margin of Neurizon Therapeutics Ltd (PAA.AX) is 79.81%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-06-30 | 79.81% |
| 2023-06-30 | 79.81% |
| 2022-06-30 | 93.03% |
| 2021-06-30 | 93.86% |
| 2020-06-30 | 94.03% |
| 2019-06-30 | 92.36% |
| 2018-06-30 | 91.22% |
| 2017-06-30 | 89.78% |
| 2016-06-30 | 91.49% |
| 2015-06-30 | 91.41% |